Similarly, higher CRABP2 levels were found in tumor tissues of stage III than in stage I patients, and also higher in lymph node metastatic (N1+) than non-metastatic (N0) patients (Fig. 2b). The gene discussed is CRABP2; the disease is neoplasm.